在马群中甲苯噻嗪和tiletamine-zolazepam麻醉。
文章的细节
-
引用
复制到剪贴板 -
哈贝尔是的,Bednarski RM,缪尔WW
在马群中甲苯噻嗪和tiletamine-zolazepam麻醉。
兽医研究》,1989 (5):737 - 42。
- PubMed ID
-
2729719 (在PubMed]
- 文摘
-
甲苯噻嗪的心肺和麻醉效果结合1:1的混合物tiletamine和zolazepam决定在6匹马。每个马有甲苯噻嗪静脉或IM,以及tiletamine-zolazepam随机4日第四次。麻醉剂被管理的速度甲苯噻嗪1.1毫克/公斤体重,第四,tiletamine-zolazepam 1.1毫克/公斤,四(1)治疗;甲苯噻嗪1.1毫克/公斤,第四,tiletamine-zolazepam 1.65毫克/公斤,四(2)治疗;甲苯噻嗪1.1毫克/公斤,第四,tiletamine-zolazepam 2.2毫克/公斤,四(3)治疗;甲苯噻嗪和2.2毫克/公斤,IM, tiletamine-zolazepam 1.65毫克/公斤,四(4)治疗。tiletamine-zolazepam剂量tiletamine + zolazepam的总和。甲苯噻嗪注射时,被tiletamine-zolazepam前5分钟。甲苯噻嗪,当给定的IM, tiletamine-zolazepam前10分钟。在所有马匹Tiletamine-zolazepam诱导休息。休息时间在1组为31.9 + / - 7.2(意思是+ / - 1 SD)分钟。 Increasing the dosage of tiletamine-zolazepam (treatments 2 and 3) significantly (P less than 0.05) increased the duration of recumbency. Xylazine caused significant (P less than 0.05) decreases in heart rate and cardiac output and significant (P less than 0.05) increases in central venous pressure and mean pulmonary artery pressure 5 minutes after administration. Respiratory rate was decreased. Arterial blood pressures increased significantly (P less than 0.05) after xylazine was administered IV in treatments 1 and 3, but the increases were not significant in treatment 2. Xylazine administered IM caused significant (P less than 0.05) increases in central venous pressure and significant (P less than 0.05) decreases in cardiac output.(ABSTRACT TRUNCATED AT 250 WORDS)
DrugBank数据引用了这篇文章
- 药物